Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Calagua C, Russo J, Sun Y, Schaefer R, Lis R, Zhang Z, et al. Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide. Clin Cancer Res. 2017;23(22):6812-6822.

Rand JH, Wu X-, Wolgast LR, Lei V, Conway EM. A novel 2-stage approach that detects complement activation in patients with antiphospholipid antibody syndrome. Thromb Res. 2017;156:119-125.

De Boer YS, Kosinski AS, Urban TJ, Zhao Z, Long N, Chalasani N, et al. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. Clin Gastroenterol Hepatol. 2017;15(1):103-112.e2.

Lee D, Fontugne J, Gumpeni N, Park K, MacDonald TY, Robinson BD, et al. Molecular alterations in prostate cancer and association with MRI features. Prostate Cancer Prostatic Dis. 2017;20(4):430-435.

Nguyen GH, Wang JY, Hymes KB, Magro CM. An Index Case of Concomitant Tumoral and Ichthyosiform Mycosis Fungoides-Like Presentation of Chronic Adult T-cell Leukemia/Lymphoma Associated With Upregulation of TOX. Am J Dermatopathol. 2017;39(1):28-32.

Kossatz S, Carney B, Schweitzer M, Carlucci G, Miloushev VZ, Maachani UB, et al. Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models. Cancer Res. 2017;77(8):2112-2123.

Alkadi MM, Kim J, Aull MJ, Schwartz JE, Lee JR, Watkins A, et al. Kidney allograft failure in the steroid-free immunosuppression era: A matched case-control study. Clin Transplant. 2017;31(11).

Natkunam Y, Goodlad JR, Chadburn A, de Jong D, Gratzinger D, Chan JK, et al. EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1. Am J Clin Pathol. 2017;147(2):129-152.

Compton ST, Kania SA, Robertson AE, Lawhon SD, Jenkins SG, Westblade LF, et al. Evaluation of Pyrrolidonyl Arylamidase Activity in Staphylococcus delphini. J Clin Microbiol. 2017;55(3):859-864.

Fei T, Chen Y, Xiao T, Li W, Cato L, Zhang P, et al. Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. Proc Natl Acad Sci U S A. 2017;114(26):E5207-E5215.